New 'Alpha' cancer drug enters human testing for Tough-to-Treat prostate cancer
Disease control
Recruiting now
This is a first-in-human study to test the safety and find the right dose of a new experimental drug called AB001 for men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The drug is a type of targeted radiation therapy designed to…
Phase: PHASE1 • Sponsor: ARTBIO Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC